Skip to main content
SpringerLink
Log in

Pharmacological Therapy for Stress Urinary Incontinence

  • Chapter
Female Urology

Part of the book series: Current Clinical Urology ((CCU))

  • 1376 Accesses

Abstract

Stress urinary incontinence (SUI) is the involuntary loss of urine with activities that increase intra-abdominal pressure, such as coughing, sneezing, and walking. Treatment options vary and include behavioral modifications, pelvic floor muscle exercises (PFMEs), barrier methods, bulking agents, and surgery. No drug approved by the Food and Drug Administration (FDA) exists for SUI. A few agents are occasionally used off label for SUI, but randomized controlled trials proving their efficacy and safety for this indication are lacking.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Kidney and Urologic Diseases Information Clearing House. Urinary Incontinence in Women, National Institutes of Health Publications No. 02–4132, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 2002.

    Google Scholar 

  2. Kinchen KS, Burgio K, Diokno AC, et al. Factors associated with women’s decisions to seek treatment for urinary incontinence. J Women’s Health 2003;12:687–698.

    Article  Google Scholar 

  3. Hunskaar S, Lose G, Sykes D, et al. The prevalence of urinary incontinence in women in four European countries. BJU Int 2004;93:324–330.

    Article  CAS  PubMed  Google Scholar 

  4. Thom DH, Nygaard IE, Calhoun EA. Urologic Diseases in American Project: urinary incontinence in women-national trends in hospitalization, office visits, treatment and economic impact. J Urol 2005; 173:1295–1301.

    Article  PubMed  Google Scholar 

  5. Mahony DT, Laferte RO, Blais DJ. Integral storage and voiding reflexes. Neurophysiologic concept of continence and micturition. Urology 1977;9:95–106.

    Article  CAS  PubMed  Google Scholar 

  6. Tonini M, Messori E, Franceschetti GP, et al. Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol 1994;113:1–2.

    CAS  PubMed  Google Scholar 

  7. Creed KE, Tulloch AGS. The action of imipramine on the lower urinary tract of the dog. Br J Urol 1982;54:5–10.

    Article  CAS  PubMed  Google Scholar 

  8. Thor KB, Donatucci C. Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women. J Urol 2004;172:27–33.

    Article  CAS  PubMed  Google Scholar 

  9. deGroat WC, Fraser MO, Yoshiyama M, et al. Neural control of the urethra. Scand J Urol Nephrol Suppl 2001;207:35–43.

    Article  Google Scholar 

  10. Thor KB. Targeting serotonin and norepinephrine receptors in stress urinary incontinence. Int J Gynaecol Obstet 2004;86:S38–S52.

    Article  CAS  PubMed  Google Scholar 

  11. Iosif CS, Batra S, Ek A, et al. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981;141:817–820.

    CAS  PubMed  Google Scholar 

  12. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257–260.

    Article  CAS  PubMed  Google Scholar 

  13. Hextall A, Bidmead J, Cardozo L, et al. Hormonal influences on the human female lower urinary tract: a prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation. Neurourol Urodyn 1999;18:282–283.

    Google Scholar 

  14. Kinn AC, Lindskog M. Oestrogens and phenylpropanolamine in combination for stress incontinence. Urology 1988;32:273–280.

    Article  CAS  PubMed  Google Scholar 

  15. Matsubara S, Okada H, Shirakawa GA, et al. Oestrogen levels influence β3-adrenoreceptor mediated relaxation of the female rat detrusor muscle. Urology 2002;59:621–625.

    Article  PubMed  Google Scholar 

  16. Smith PJB. The effect of oestrogens on bladder function in the female. In: The Management of the Menopause and Postmenopausal Years (Campbell S, ed.), MTP, Carnforth, UK. 1976, pp. 291–298.

    Google Scholar 

  17. Robinson D, Cardozo L. Oestrogens and the lower urinary tract. BJOG 2004; 111:10–14.

    Article  CAS  PubMed  Google Scholar 

  18. Rud T. The effects of oestrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent females. Acta Obstet Gynaecol Scand 1980;59:265–270.

    Article  CAS  Google Scholar 

  19. Zullo MA, Oliva C, Falconi G, et al. Efficacy of oestrogen therapy in urinary incontinence. A metaanalytic study. Minerva Ginecol 1998;50:199–205.

    CAS  PubMed  Google Scholar 

  20. Fantl JA, Bump RC, Robinson D, et al. Efficacy of oestrogen supplementation in the treatment of urinary incontinence. Obstet Gynaecol 1996;88:745–749.

    Article  CAS  Google Scholar 

  21. Sultana CJ, Walters MD. Oestrogen and urinary incontinence in women. Maturitas 1995;20:129–138.

    Article  Google Scholar 

  22. Moerher B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003;(2):CD001405.

    Google Scholar 

  23. Hextall A. Oestrogens and lower urinary tract functions. Maturitas 2002;36:83–87.

    Article  Google Scholar 

  24. Jackson S, Shepherd A, Brookes S, et al. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind, placebo controlled trial. Br J Obstet Gynaecol 1999; 106: 711–718.

    CAS  PubMed  Google Scholar 

  25. Grady D, Brown JS, Vittinghoff E, et al. Postmenopausal hormones and incontinence: the heart and estrogen/progestin replacement study. Obstet Gynecol 2001;97:116–120.

    Article  CAS  PubMed  Google Scholar 

  26. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin in urinary incontinence. JAMA 2005;293:935–948.

    Article  CAS  PubMed  Google Scholar 

  27. Khanna OP, Heber D, Gonick P. Cholinergic and adrenergic neuroreceptors in urinary tract of female dogs; evaluation of function with pharmaco-dynamics. Urology 1975;5:616–623.

    Article  CAS  PubMed  Google Scholar 

  28. Hunsballe JM, Djurhuus JC. Clinical options for imipramine in the management of urinary incontinence. Urol Res 2001;29:118–125.

    Article  CAS  PubMed  Google Scholar 

  29. Zinner NR, Koke SC, Viktrup L. Pharmacotherapy for stress urinary incontinence: present and future options. Drugs 2004;64:1503–1516.

    Article  PubMed  Google Scholar 

  30. Labay P, Boyarsky S. The action of imipramine on the bladder musculature. J Urol 1973;109:385–387.

    CAS  PubMed  Google Scholar 

  31. Tomasi PA, Siracusano S, Monni AM, et al. Decreased nocturnal urinary antidiuretic hormone excretion in enuresis is increased by imipramine. BJU Int 2001;88:932–937.

    Article  CAS  PubMed  Google Scholar 

  32. Gilja I, Radej M, Kovacic M, et al. Conservative treatment of female stress incontinence with imipramine. J Urol 1984;132:909–911.

    CAS  PubMed  Google Scholar 

  33. Lin HH, Sheu BC, Lo MC, et al. Comparison of treatment outcomes for imipramine for female genuine stress incontinence. Br J Obstet Gynaecol 1999;106:1089–1092.

    CAS  PubMed  Google Scholar 

  34. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997;17:2S–18S.

    Article  CAS  PubMed  Google Scholar 

  35. Viktrup L, Bump RC. Pharmacological agents used for the treatment of stress urinary incontinence in women. Curr Med Res Opin 2003;19:485–490.

    Article  CAS  PubMed  Google Scholar 

  36. Diokno A, Taub M. Ephedrine in treatment of urinary incontinence. Urology 1975;5:624–627.

    Article  CAS  PubMed  Google Scholar 

  37. Bishop MJ, Barvian KA, Berman J, et al. α1-Adrenoceptor agonists: the identification of novel α1A subtype selective 2-heteroaryl-2-(phenoxymethyl) imidazolines. Bioorg Med Chem Lett 2002;12:471–475.

    Article  CAS  PubMed  Google Scholar 

  38. Radley SC, Chappelle CR, Bryan NP, et al. Effect of methoxamine on maximum urethral pressure in women with GSI; a placebo-controlled, double-blind crossover study. Neurourol Urodyn 2001;20:43–52.

    Article  CAS  PubMed  Google Scholar 

  39. Nishimatsu H, Moriyama KH, Hamada Y, et al. Contractile response to α1-adrenoceptor agonists in isolated human male and female urethra. BJU Int 1999;84:515–520.

    Article  CAS  PubMed  Google Scholar 

  40. Musselman DM, Ford AP, Gennevois DJ, et al. A randomized crossover study to evaluate Ro 115–1240, a selective α1A/1L adrenoceptor partial agonist in women with stress urinary incontinence. BJU Int 2004;93:78–83.

    Article  CAS  PubMed  Google Scholar 

  41. Wein AJ. A randomized crossover study to evaluate Ro 115–1240, a selective α1A/1L adrenoceptor partial agonist in women with stress urinary incontinence [editorial comment]. BJU Int 2004;93:1115.

    Article  CAS  PubMed  Google Scholar 

  42. Yasuda K, Kawabe K, Takimoto Y, et al. A double-blind clinical trial of β2-adrenergic agonist in stress incontinence. Int Urogynecol J 1993;4:146–151.

    Article  Google Scholar 

  43. Ishiko O, Ushiroyama T, Saji F, et al. β2-Adrenergic agonists and pelvic floor exercises for female stress incontinence. Int J Gynaecol Obstet 2000;71:39–44.

    Article  CAS  PubMed  Google Scholar 

  44. Gleason DM, Reilly RJ, Bottacini MR, et al. The urethral continence zone and its relation to stress incontinence. J Urol 1974;112:81–88.

    CAS  PubMed  Google Scholar 

  45. Kaisary AV. β-Adrenoceptor blockade in the treatment of female urinary stress incontinence. J Urol 1984;90:351–353.

    CAS  Google Scholar 

  46. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995;274:1014–1024.

    CAS  PubMed  Google Scholar 

  47. Norton PA, Zinner NR, Yalcin I, et al. Duloxetine vs placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002; 187:40–48.

    Article  CAS  PubMed  Google Scholar 

  48. Dmochowski RR, Miklos JR, Norton PA, et al. Duloxetine vs placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003;170:1259–1263. Erratum in: J Urol 2004;171:360.

    Article  CAS  PubMed  Google Scholar 

  49. Van Kerrebroeck P, Abrams P, Lange R, et al. Duloxetine vs placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004;111:249–257.

    Article  PubMed  Google Scholar 

  50. Millard RJ, Moore K, Rencken R, et al. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int 2004;93:311–318.

    Article  CAS  PubMed  Google Scholar 

  51. Cardozo L, Drutz HP, Baygani SK, et al. Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 2004;104:511–519.

    CAS  PubMed  Google Scholar 

  52. Ghoniem GM, Van Leeuwen JS, Elser DM, et al. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol 2005;173:1647–1653.

    Article  CAS  PubMed  Google Scholar 

  53. US Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/drug/infopage/ default.htm.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN

    Harriette M. Scarpero MD

Authors
  1. Harriette M. Scarpero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Female Urology and Voiding Dysfunction The Glickman Urological Institute, The Cleveland Clinic, Cleveland, Ohio

    Howard B. Goldman MD  & Sandip P. Vasavada MD  & 

  2. Department of Urology and Reproductive Biology, CASE School of Medicine, Cleveland, Ohio

    Howard B. Goldman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Scarpero, H.M. (2007). Pharmacological Therapy for Stress Urinary Incontinence. In: Goldman, H.B., Vasavada, S.P. (eds) Female Urology. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-368-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-368-4_7

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-701-3

  • Online ISBN: 978-1-59745-368-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation